We are live on ! Find out more
BIOS

BioPlus Acquisition Corp. Class A Ordinary Shares

Delisted

BIOS was delisted on the 6th of October, 2023.

30 hedge funds and large institutions have $135M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

1% more capital invested

Capital invested by funds: $134M → $135M (+$1.36M)

6% less funds holding

Funds holding: 3230 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
30
Holders Change
-2
Holders Change %
-6.25%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
4
Increased
4
Reduced
3
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
ETH
26
Exos TFP Holdings
New York
$650K
AMC
27
Atlas Merchant Capital
New York
$542K
VF
28
Virtu Financial
New York
$221K +$219K +20,445 New
KIM
29
Karpus Investment Management
New York
$111K
CS
30
Clear Street
New York
$11 +$11 +1 New
QL
31
Quarry LP
New York
-$4.85M -455,000 Closed
SFM
32
Spartan Fund Management
Canada
-$3.41M -270,578 Closed
PCM
33
Prelude Capital Management
New York
-$1.6M -150,000 Closed
OCM
34
Oaktree Capital Management
California
-$1.06M -100,000 Closed
Bank of Montreal
35
Bank of Montreal
Ontario, Canada
-$753K -68,435 Closed
UBS Group
36
UBS Group
Switzerland
-$19.5K -1,828 Closed